Integra Lifesciences
(NASDAQ:IART)
$26.38
-0.09[-0.34%]
Last update: 9:29AM Get Real Time Here
37.5%
Overview Rating
Speculative
Technicals Analysis
33
0100
Financials Analysis
40
0100
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
0
0
0
0
Feb
0
0
0
0
Mar
1
Apr
1
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IART
SIBN

FAQ

Q

How do I buy Integra Lifesciences (IART) stock?

A

You can purchase shares of Integra Lifesciences (NASDAQ: IART) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Integra Lifesciences's (IART) competitors?

Q

What is the target price for Integra Lifesciences (IART) stock?

A

The latest price target for Integra Lifesciences (NASDAQ: IART) was reported by Morgan Stanley on Tuesday, May 7, 2024. The analyst firm set a price target for 24.00 expecting IART to fall to within 12 months (a possible -10.06% downside). 26 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Integra Lifesciences (IART)?

A

The stock price for Integra Lifesciences (NASDAQ: IART) is $26.685 last updated Today at May 16, 2024 at 10:12 AM EDT.

Q

Does Integra Lifesciences (IART) pay a dividend?

A

There are no upcoming dividends for Integra Lifesciences.

Q

When is Integra Lifesciences (NASDAQ:IART) reporting earnings?

A

Integra Lifesciences’s Q2 earnings are confirmed for Wednesday, July 24, 2024.

Q

Is Integra Lifesciences (IART) going to split?

A

There is no upcoming split for Integra Lifesciences.

Q

What sector and industry does Integra Lifesciences (IART) operate in?

A

Integra Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

People Also Watch